You are here

Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Typesort descending Project # RFA # PI/Project Leader Institution Title Status
2009 R33 CA137673 RFA-CA-08-008 BEEBE, DAVID J UNIVERSITY OF WISCONSIN-MADISON MICROCHANNEL CELL-BASED ASSAYS TO ENABLE CANCER RESEARCH Complete
2013 R33 CA177461 RFA-CA-12-003 FURDUI, CRISTINA MARIA WAKE FOREST UNIVERSITY HEALTH SCIENCES NEW REAGENTS FOR TRACKING PROTEIN OXIDATION IN CELLS BY MS AND IMAGING METHODS Complete
2020 R33 CA247739 RFA-CA-19-020 MATRIX BHATNAGAR, PARIJAT SRI INTERNATIONAL T-cell Biofactories For Targeting Extracellular Matrix Active
2018 R33 CA225863 RFA-CA-17-011 LU, JUN YALE UNIVERSITY CRISPR-based Enhanced Molecular Chipper Technology for Identifying Functional Noncoding Elements in Cancer NCE
2007 R33 CA120726 RFA-CA-07-002 MOORE, PATRICK S. UNIVERSITY OF PITTSBURGH AT PITTSBURGH EMERGING TECHNOLOGIES APPLIED TO THE DISCOVERY OF HUMAN TUMOR VIRUSES Complete
2014 R33 CA177333 RFA-CA-13-002 FEDERSPIEL, MARK J MAYO CLINIC ROCHESTER VALIDATING TECHNOLOGY TO OPTIMIZE ANTIBODY AFFINITY FOR TARGETING THERAPEUTICS Complete
2017 R33 CA212697 RFA-CA-16-002 KLEIN, ALLON MOSHE HARVARD MEDICAL SCHOOL Droplet microfluidic technology for single cell cancer genomics Complete
2001 R33 CA084691 PAR-98-067 MELDRUM, DEIRDRE R. UNIVERSITY OF WASHINGTON AUTOMATED MINIMAL RESIDUAL DISEASE QUANTIFICATION Complete
2009 R33 CA134304 RFA-CA-08-008 SHI, HUIDONG GEORGIA REGENTS UNIVERSITY APPLICATION OF 454 SEQUENCING TO CANCER EPIGENOMICS Complete
2013 R33 CA177462 RFA-CA-12-003 BAILEY, RYAN C UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN MESO-PLEX MIRNA AND PROTEIN PROFILING FOR CANCER DIAGNOSTICS USING CHIP-INTEGRATE Complete
2020 R33 CA240181 RFA-CA-19-020 COOKS, ROBERT GRAHAM PURDUE UNIVERSITY Advanced Development Of Desorption Electrospray Ionization Mass Spectrometry For Intraoperative Molecular Diagnosis Of Brain Cancer Using Pathology Biopsies Active
2019 R33 CA225458 RFA-CA-18-003 KETTENBACH, ARMINJA NADINE DARTMOUTH COLLEGE Activity based profiling of Phosphoprotein phosphatases in cancer using mass spectrometry-based proteomics Active
2002 R33 CA096309 PAR-01-104 LI, HONGHUA UNIV OF MED/DENT NJ-R W JOHNSON MED SCH A GENETIC APPROACH TO GENOME-SCALE ANALYSIS OF CANCERS Complete
2018 R33 CA222344 RFA-CA-17-011 SALIPANTE, STEPHEN J UNIVERSITY OF WASHINGTON Advanced development and validation of genome-scale molecular diagnostics for microsatelliteinstability using targeted molecular counting methods NCE
2007 R33 CA122900 RFA-CA-07-002 DOVICHI, NORMAN J UNIVERSITY OF WASHINGTON CHEMICAL CYTOMETRY FOR NEOPLASIA PROGNOSIS-BARRETT'S ESOPHAGUS Complete
2014 R33 CA177449 RFA-CA-13-002 BLAIR, SARAH L UNIVERSITY OF CALIFORNIA SAN DIEGO NON-CIRCULATING MICROPARTICLES FOR IMPROVED LOCALIZATION AND RESECTION CANCER Complete
2017 R33 CA212806 RFA-CA-16-004 ZILBERBERG, JENNY HACKENSACK UNIVERSITY MEDICAL CENTER Ex vivo culture platform validation for preservation of patient derived multiple myeloma cells NCE
2001 R33 CA084740 PAR-98-067 ENGELWARD, BEVIN P. MASSACHUSETTS INSTITUTE OF TECHNOLOGY FLUORESCENCE DETECTION OF GENETIC INSTABILITY IN MICE Complete
2009 R33 CA140039 RFA-CA-08-008 ELLEDGE, STEPHEN J BRIGHAM AND WOMEN'S HOSPITAL A MULTIPLEX GENOME-WIDE SHRNA SCREENING PLATFORM FOR CANCER-LETHAL GENE DISCOVERY Complete
2013 R33 CA177456 RFA-CA-12-003 DI CARLO, DINO UNIVERSITY OF CALIFORNIA LOS ANGELES ISOLATING CIRCULATING TUMOR CELLS USING A CENTRIFUGE ON A CHIP Complete
2019 R33 CA225498 RFA-CA-18-003 CHEN, SIDI YALE UNIVERSITY Rapidly scalable platforms for direct in vivo screening of functional drivers in lethal cancers Active
2007 R41 CA128782 RFA-CA-07-011 CAO, HAN BIONANOMATRIX, INC. CONTINUOUS CHROMOSOME SORTING WITH MICRO/NANOFLUIDICS Complete
2006 R41 CA118625 RFA-CA-06-006 HIRSCHOWITZ, EDWARD A 20/20 GENESYSTEMS, INC. AUTO-ANTIBODY PROFILING OF NON-SMALL CELL LUNG CANCER Complete
1999 R41 CA081825 PAR-98-066 MACH, ROBERT H ANASAZI BIOMEDICAL RESEARCH, INC. SIGMA 1 RECEPTOR PROBES FOR IMAGING TUMOR PROLIFERATION Complete
2001 R41 CA088384 PAR-99-101 SULK, ROBERTA A DELTANU, LLC ONE STEP H. PYLORI TEST--SCREENING AND INDIVIDUAL ASSAYS Complete
2000 R41 CA083369 PAR-98-066 SWENBERG, JAMES A ENO RIVER LABS, LLC ULTRASENSITIVE METHODS FOR HUMAN DNA ADDUCT QUANTITATION Complete
2000 R41 CA084688 PAR-98-066 SKIPPER, PAUL L NEWTON SCIENTIFIC, INC. TRITIUM AMS ANALYSIS OF CANCER BIOMARKERS Complete
2000 R41 CA084693 PAR-98-066 LIFSHITZ, NADIA BIOPHOTONICS CORPORATION MONOLITHIC MULTI-CAPILLARY ARRAYS TO SEQUENCE DNA Complete
2003 R41 CA103103 PAR-01-105 SANTANGELO, PHILIP J VIVONETICS, INC. IN VIVO GENE EXPRESSION IMAGING FOR CANCER ANALYSIS Complete
2003 R41 CA103120 PAR-01-105 GUTHOLD, MARTIN NANOMEDICA, INC. NOVEL, SINGLE-MOLECULE APTAMER SELECTION METHOD Complete
2009 R42 CA140109 RFA-CA-08-012 GORBOVITSKI, BORIS ADVANCED BIOMEDICAL MACHINES, INC. DATA ACQUISITION SYSTEM FOR MULTIPLEX ANALYSIS OF COLOR ENCODED PARTICLES Complete
2007 R42 CA116048 RFA-CA-07-011 RAMPERSAUD, ARFAAN COLUMBUS NANOWORKS, INC. COMMERCIALIZATION OF MAGNETIC NANOBEADS FOR CANCER CELL ENRICHMENT Complete
2010 R42 CA140109 RFA-CA-08-012 GORBOVITSKI, BORIS ADVANCED BIOMEDICAL MACHINES, INC. DATA ACQUISITION SYSTEM FOR MULTIPLEX ANALYSIS OF COLOR ENCODED PARTICLES Complete
2008 R42 CA122715 RFA-CA-07-044 SAXENA, SATYA PRAKASH CALIBRANT BIOSYSTEMS, INC. VALIDATION AND QUANTIFICATION OF FFPE ANTIGEN RETRIEVAL BY PROTEOME ANALYSIS Complete
2006 R42 CA103103 RFA-CA-05-006 BAO, GANG VIVONETICS, INC. IN VIVO GENE DETECTION FOR CANCER ANALYSIS Complete
2002 R42 ES011746 PAR-99-101 SWENBERG, JAMES A ENO RIVER LABS, LLC ULTRASENSITIVE METHODS FOR HUMAN BIOMARKER QUANTITATION Complete
2004 R42 CA084688 PAR-01-105 SKIPPER, PAUL L NEWTON SCIENTIFIC, INC. TRITUM AMS ANALYSIS OF CANCER BIOMARKERS Complete
1999 R43 CA081951 PAR-98-066 XANTHOPOULOS, KLEANTHIS G AURORA BIOSCIENCES CORPORATION ID OF NOVEL BREAST CANCER AGENTS BY FUNCTIONAL GENOMICS Complete
2001 R43 CA084679 PAR-98-066 PERLIN, MARK W CYBERGENETICS CORPORATION AUTOMATED MULTIPLEX GENETIC ANALYSIS TECHNOLOGY Complete
2004 R43 CA108005 PAR-01-105 HEILIG, JOSEPH S SOMALOGIC, INC. APTAMER DEVELOPMENT FOR CANCER DIAGNOSIS AND MANAGEMENT Complete
2003 R43 CA099111 PAR-01-105 SHEN, LI SUPERARRAY BIOSCIENCE CORPORATION ID-TAG PROTEIN PROFILING ARRAY FOR THE MOLECULAR CHARACT Complete
2000 R43 CA084679 PAR-98-066 PERLIN, MARK W CYBERGENETICS CORPORATION AUTOMATED MULTIPLEX GENETIC ANALYSIS TECHNOLOGY Complete
2002 R43 CA096065 PAR-01-105 GAU, VINCENT JEN-JR GENEFLUIDICS, INC. RAPID MOLECULAR DETECTION OF PML/RARALPHA Complete
1999 R43 CA081952 PAR-98-066 CHEE, MARK S. ILLUMINA, INC. GENE EXPRESSION ANALYSIS ON RANDOMLY ORDERED DNA ARRAYS Complete
2003 R43 CA101271 PAR-01-105 DIATCHENKO, LUDA ATTAGENE, INC. PROFILING OF SIGNAL TRANSDUCTION PATHWAYS IN CANCER Complete
2009 R43 CA137737 RFA-CA-08-011 ZWICK, MICHAEL G ANDROBIOSYS, INC. PRIMARY XENOGRAFTS OF HUMAN TISSUE AS SURROGATES OF CANCER IN SITU Complete
2000 R43 CA084686 PAR-98-066 BOGEN, STEVEN A CYTOLOGIX CORPORATION INSTRUMENTATION FOR IN SITU ANALYSIS TUMORS Complete
2002 R43 CA096069 PAR-01-105 YANG, XING GENEOHM SCIENCES, INC. MULTIPLEXED DNA-MEDIATED ELECTOCHEMICAL SENSORS Complete
1999 R43 CA081958 PAR-98-066 HAGEN, FREDERICK S ICOGENEX CORPORATION AFFINITY AND TRANSCRIPTASE TECHNOLOGIES Complete
2003 R43 CA102986 PAR-01-105 KRIZMAN, DAVID BURKE EXPRESSION PATHOLOGY, INC PROTEIN ARRAYS FOR MOLECULAR ANALYSIS OF CANCER TISSUE Complete

Pages



National Cancer Institute at the National Institutes of Health

 

NIH… Turning Discovery Into Health®